Aptose Biosciences Inc
OTC:APTOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aptose Biosciences Inc
OTC:APTOF
|
CA |
|
P
|
Prosus NV
JSE:PRX
|
NL |
|
V
|
Vinci SA
F:SQUA
|
FR |
|
General Electric Co
F:GCP
|
US |
|
T
|
Tencent Holdings Ltd
XMUN:NNN1
|
CN |
|
K
|
KCE Electronics PCL
SET:KCE
|
TH |
|
Banco Bilbao Vizcaya Argentaria SA
NYSE:BBVA
|
ES |
|
F
|
Fortive Corp
SWB:F03
|
US |
|
Pharmagest Interactive SA
F:PHF
|
FR |
|
M
|
McDonald's Holdings Company Japan Ltd
XMUN:MJ8
|
JP |
|
Kko International SA
PAR:ALKKO
|
BE |
|
C
|
China Southern Airlines Co Ltd
XMUN:ZNHH
|
CN |
|
BlackBerry Ltd
TSX:BB
|
CA |
|
E
|
Electronic Arts Inc
XBER:ERT
|
US |
|
P
|
Pioneer Natural Resources Co
F:PNK
|
US |
|
Viscofan SA
F:VIS
|
ES |
|
L
|
Leviathan Gold Ltd
F:0GP
|
CA |
|
S
|
Sumitomo Chemical Co Ltd
F:SMM
|
JP |
|
J
|
JOYY Inc
DUS:0YYA
|
SG |
Bankruptcy Probability
Aptose Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptose Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
5.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
175.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptose Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptose Biosciences Inc has total debt of 10m USD. This includes both short-term (0 USD) and long-term (10m USD) debt.
You can find a full breakdown on its Balance Sheet.
